Cytokinetics Inc vs Ingersoll Rand — how do they compare? Cytokinetics Inc trades at $62.75 (market cap $8.62B), while Ingersoll Rand trades at $78.53 (market cap $30.26B). The key difference: Ingersoll Rand is far larger — about 3.5× Cytokinetics Inc's market cap, and Ingersoll Rand pays a 0.1% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Ingersoll Rand for 7 Days on average.
| CYTK | IR | |
|---|---|---|
Market Cap | $8.62B | $30.26B |
Volume | 2,594,626 | 4,017,622 |
Sector | Health | Industrials |
52-Week High | $87.26 | $98.76 |
52-Week Low | $54.76 | $68.54 |
Typical Hold Time | 19 Days | 7 Days |
Enterprise Value | $8.72B | $33.92B |
Dividend Yield | — | 0.1% |
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $62.48, up 2.23% today, but faces bearish technical signals with 18 sell indicators versus 4 buy signals. The company shows strong revenue growth potential with recent positive Phase 3 trial results for aficamten in non-obstructive HCM, though it operates at significant losses with a -1,321% net income margin. Cash flow remains heavily dependent on financing activities, with operating cash flow negative at -$555 million in 2026.
Wall Street maintains strong bullish sentiment with 97% buy ratings and a $112.60 consensus price target, representing 80% upside potential. Key risks include continued cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization of pipeline drugs. The stock's valuation appears stretched at 114x sales given current financial performance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →